Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Art Bechhoefer who wrote (2555)	4/26/1999 10:47:00 AM
From: Gator II	Respond to of 4676

Art...Have you ever looked at Enzo Biochem (ENZ) on the amex? No debt, profitable, thriving diagnostic division, and a number of patents involving antisense technology. I'm not hyping ENZ, just wondering whether you are aware of them and if you are, whether you have an opinion about their prospects in this field. It's my understanding ENZ has no investment banker analyst coverage and it's reputation on the Street suffers from alleged hypes by individual broker's (in the past) when they were always "on the verge" of a breakthrough, about to gain analyst coverage, or about to ink deals with major pharmaceutical companies, etc., etc. Management is apparently dominated by family, isn't concerned about image and more interested in awards for science than Wall St recognition. All things considered and specifically in regard to antisense, I (very much a non-technical type) do believe they are a player in this technology and am somewhat baffled by their lack of recognition and/or coverage. IMO, ENZ is either a diamond in the rough and not being taken seriously or they really are not a player but their patents (omni in nature and, I believe, at least one court case offered support to their claims) and shouldn't, as you didn't, be included in an analysis of antisense technology players. Art, in particular, I was prompted to respond to your post in light of your statement that, "ISIS is the ONLY antisense company in good enough financial condition to attract investors." You may very well be right but ENZ's financial position IS quite good for a small biotech but maybe I'm wrong and they are not a player along with ISIP in this field. Regardless, I'm looking forward to your thoughts... Gator II